Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma, Progesterone Receptor Negative, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Triple-Negative Breast Carcinoma
Study Phase
Phase 3
Study Completion Date
May 2021
NCT02445391Uploaded 09-23-2022
Access via NCI by Request
PDS UID: nci-data-495
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Files: NCT02445391-D1
Data DictionaryNCT02445391-D1-Data-Dictionary_0.pdf
DATANCT02445391-D1-Dataset_0.csv
OTHERREADME.pdf
Files: NCT02445391-D2
Data DictionaryNCT02445391-D2-Data-Dictionary_0.pdf
DATANCT02445391-D2-Dataset_0.csv
OTHERREADME.pdf
Files: NCT02445391-D3
Data DictionaryNCT02445391-D3-Data-Dictionary_0.pdf
DATANCT02445391-D3-Dataset.csv
OTHERREADME.pdf